HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott N Byrne Selected Research

CIS 19

6/2017Evolving Identification of Blood Cells Associated with Clinically Isolated Syndrome: Importance of Time since Clinical Presentation and Diagnostic MRI.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott N Byrne Research Topics

Disease

10Multiple Sclerosis
01/2022 - 10/2015
8Skin Neoplasms (Skin Cancer)
07/2020 - 10/2002
6Neoplasms (Cancer)
01/2020 - 12/2002
3Inflammation (Inflammations)
01/2016 - 10/2006
2Lymphatic Metastasis
01/2020 - 04/2014
2Sunburn
01/2016 - 04/2015
2Hypersensitivity (Allergy)
01/2016 - 01/2009
2Carcinogenesis
04/2015 - 01/2015
1Autoimmune Diseases (Autoimmune Disease)
07/2020
1Asthma (Bronchial Asthma)
01/2019
1Autistic Disorder (Autism)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
01/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2019
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2019
1Schizophrenia (Dementia Praecox)
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2016
1Disease Progression
10/2015
1Delayed Hypersensitivity (Hypersensitivity, Type IV)
04/2015
1Neoplasm Metastasis (Metastasis)
04/2014
1Melanoma (Melanoma, Malignant)
04/2014
1Contact Dermatitis (Eczema, Contact)
03/2013
1Gout
03/2013
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2005
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2002

Drug/Important Bio-Agent (IBA)

3Vitamin DFDA LinkGeneric
01/2021 - 10/2015
2Cholecalciferol (Vitamin D3)FDA Link
01/2021 - 01/2019
2AntigensIBA
01/2015 - 01/2009
2Proteins (Proteins, Gene)FDA Link
01/2015 - 01/2015
2LipidsIBA
01/2015 - 10/2006
2DNA (Deoxyribonucleic Acid)IBA
01/2015 - 01/2014
2plerixaforFDA Link
04/2014 - 01/2014
1Vitamin D3 24-HydroxylaseIBA
01/2021
1Fingolimod Hydrochloride (FTY720)FDA Link
12/2020
1platelet activating factor receptorIBA
07/2020
1Immunoglobulin G (IgG)IBA
05/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2019
1Interleukin-10 (Interleukin 10)IBA
01/2019
1EnzymesIBA
01/2018
1Tryptophan (L-Tryptophan)FDA Link
01/2018
1CytokinesIBA
01/2018
1Arginine (L-Arginine)FDA Link
01/2018
1Immunoglobulins (Immunoglobulin)IBA
01/2018
1CIS 19IBA
06/2017
1Pathogen-Associated Molecular Pattern MoleculesIBA
12/2016
1Antimicrobial PeptidesIBA
12/2016
1RNA (Ribonucleic Acid)IBA
12/2016
1Toll-Like Receptors (Toll-Like Receptor)IBA
12/2016
1InflammasomesIBA
12/2016
1Serotonin (5 Hydroxytryptamine)IBA
01/2016
1Cyproheptadine (Periactin)FDA Link
01/2016
1KetanserinIBA
01/2016
1Complement Factor B (Factor B)IBA
04/2015
1Biological ProductsIBA
04/2015
1Complement System Proteins (Complement)IBA
04/2015
1Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA
01/2015
1Polysaccharides (Glycans)IBA
01/2015
1Glycoproteins (Glycoprotein)IBA
01/2015
1GlycopeptidesIBA
01/2015
1VaccinesIBA
01/2015
1GlycosyltransferasesIBA
01/2015
1CarbohydratesIBA
01/2015
1Mucin-1 (CA 15-3 Antigen)IBA
01/2015
1Cancer VaccinesIBA
01/2015
1Surface Antigens (Surface Antigen)IBA
04/2014
1Biomarkers (Surrogate Marker)IBA
04/2014
1ChemokinesIBA
04/2014
1SuspensionsIBA
04/2014
1Allopurinol (Remid)FDA LinkGeneric
03/2013
1Pharmaceutical PreparationsIBA
03/2013
1Uric Acid (Urate)IBA
03/2013
1DNA Repair EnzymesIBA
12/2011
1Transforming Growth Factor beta (TGF-beta)IBA
01/2008
1Platelet Activating FactorIBA
10/2006
1CarcinogensIBA
10/2006
1Transforming Growth Factor beta1 (TGF beta 1)IBA
09/2005

Therapy/Procedure

3Phototherapy (Light Therapy)
07/2020 - 12/2016
3Immunotherapy
01/2020 - 12/2002
2Therapeutics
01/2022 - 05/2020
2Immunomodulation
01/2019 - 10/2002
1Drug Therapy (Chemotherapy)
01/2019